Connect with us

Chronic Illness

A New Pathway to Slowing Pulmonary Fibrosis: Inhibiting Piezo2 Signaling

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor that senses mechanical forces in tissues including stress, strain, and stiffness. The new study sheds light on the underlying mechanisms of pulmonary fibrotic diseases and identifies potential new targets and options for therapy to improve patients’ outcomes.

Avatar photo

Published

on

The discovery of a novel pathway to slow the progression of pulmonary fibrosis has brought hope to patients suffering from this devastating disease. Researchers have found that inhibiting the expression or function of Piezo2, a receptor that senses mechanical forces in tissues, could be a potential new therapeutic route for treating lung fibrosis and other fibrotic diseases.

Pulmonary fibrotic diseases are a group of conditions characterized by significant morbidity and sometimes mortality. Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with a median survival of 2.9 years from diagnosis. Lung fibrosis results in dramatic mechanical changes, including increased stiffness in the tissue that cells can sense and respond to, making it difficult for the lungs to expand and contract properly during breathing.

The discovery of Piezo channels has garnered significant interest since Dr. Ardem Patapoutian was awarded the Nobel Prize in Medicine in 2021. However, little has been published on their possible role in fibrotic lung diseases. Researchers have investigated the role of Piezo2 in pulmonary fibrosis using donor tissue from patients with IPF, mouse models of lung fibrosis, cell culture investigation of lung cells (fibroblasts) that create the fibrosis lesions, and by examining publicly available RNAseq datasets from other research groups.

The findings suggest that inhibiting expression or function of Piezo2 could be a potential new therapeutic route to treating lung fibrosis and other fibrotic diseases. This is especially important as there is an unmet need for additional therapies for fibrotic diseases. Despite the introduction of nintedanib and pirfenidone for therapy of some fibrotic lung diseases, pulmonary fibrosis can remain challenging to effectively treat.

The researchers believe that blocking Piezo2 signaling to prevent fibroblast reprogramming represents a new pathway they can target in their fight against fibrosis. This research identifies mechanical forces and a specific target (Piezo2) that can be blocked to prevent fibrotic reprogramming of some lung cells. They conclude that this points to Piezo2 as an important new therapeutic target that might slow the progression of pulmonary fibrosis in patients.

This breakthrough has the potential to accelerate development and increase interest from pharmaceutical partners, ultimately leading to improved outcomes for patients suffering from fibrotic diseases.

Chronic Illness

Unraveling Memory Formation: A Computational Model Reveals New Insights into Protein Structures at Synapses

Complex protein interactions at synapses are essential for memory formation in our brains, but the mechanisms behind these processes remain poorly understood. Now, researchers have developed a computational model revealing new insights into the unique droplet-inside-droplet structures that memory-related proteins form at synapses. They discovered that the shape characteristics of a memory-related protein are crucial for the formation of these structures, which could shed light on the nature of various neurological disorders.

Avatar photo

Published

on

Memory formation is one of the brain’s most fundamental and complex functions, yet the microscopic mechanisms behind it remain poorly understood. Recent research has highlighted the importance of biochemical reactions occurring at postsynaptic densities – specialized areas where neurons connect and communicate. These tiny junctions between brain cells are now thought to be crucial sites where proteins need to organize in specific ways to facilitate learning and memory formation.

A 2021 study revealed that memory-related proteins can bind together to form droplet-like structures at postsynaptic densities, which scientists believe may be fundamental to how our brains create lasting memories. However, understanding exactly how and why such complex protein arrangements form has remained a significant challenge in neuroscience.

Against this backdrop, a research team led by Researcher Vikas Pandey from the International Center for Brain Science (ICBS), Fujita Health University, Japan, has developed an innovative computational model that reproduces these intricate protein structures. Their paper, published online in Cell Reports on April 07, 2025, explores the mechanisms behind the formation of multilayered protein condensates.

The researchers focused on four proteins found at synapses, with special attention to Ca²⁺/calmodulin-dependent protein kinase II (CaMKII) – a protein particularly abundant in postsynaptic densities. Using computational modeling techniques, they simulated how these proteins interact and organize themselves under various conditions. Their model successfully reproduced the formation of the above-mentioned “droplet-inside-droplet” structures observed in earlier experiments.

Through simulations and detailed analyses of the physical forces and chemical interactions involved, the research team shed light on a process called liquid-liquid phase separation (LLPS); it involves proteins spontaneously organizing into condensates without membranes that sometimes resemble the organelles found inside cells. Crucially, the researchers found that the distinctive “droplet-inside-droplet” structure appears as a result of competitive binding between the proteins and is significantly influenced by the shape of CaMKII, specifically its high valency (number of binding sites) and short linker length.

These findings could pave the way toward a better understanding of the possible mechanisms of memory formation in humans. However, the long-term implications of this research extend well beyond basic neuroscience. Defects in synapse formation have been associated with numerous neurological and mental health conditions, including schizophrenia, autism spectrum disorders, Down syndrome, and Rett syndrome.

“Our results revealed new structure-function relationships between proteins at synapses,” said Dr. Pandey. “We hope that our findings will contribute to the development of novel therapeutic strategies for these devastating diseases.”

The project received funding from various organizations, including the Core Research for Evolutional Science and Technology (CREST), the Japan Science and Technology Agency (JST), JSPS KAKENHI, Kobayashi foundation, ISHIZUE2024 of Kyoto University, Grant-in-Aid for Scientific Research JP18H05434, and others.

References:

* Pandey, V., et al. (2025). Unraveling memory formation: A computational model reveals new insights into protein structures at synapses. Cell Reports.
* Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT). (n.d.). Research Grants JP18H05434 and JP20K21462.

Continue Reading

Alzheimer's

Unraveling the Mystery of Parkinson’s Disease: New Key Genes Identified Using CRISPR Technology

A longstanding mystery in Parkinson’s disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also carry such variants do not. The prevailing theory has suggested additional genetic factors may play a role. To address this question, a new study used modern technology, called CRISPR interference, to systematically examine every gene in the human genome. The scientists identified a new set of genes that contribute to the risk of Parkinson’s disease, which opens the door to previously untapped drug targets for treating PD.

Avatar photo

Published

on

Parkinson’s disease, a neurodegenerative disorder that affects over 10 million people worldwide, has long been shrouded in mystery. While some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, others who also carry such variants remain unaffected. A new study from Northwestern Medicine has shed light on this enigma by identifying a set of key genes that contribute to the manifestation of Parkinson’s disease.

Using modern CRISPR technology, scientists at Northwestern Medicine systematically examined every gene in the human genome, leading them to identify a group of 16 proteins called Commander complex. This complex plays an important role in delivering specific proteins to the lysosome, a part of the cell responsible for recycling waste materials and old cell parts. Previous research has found that carrying a pathogenic variant in the GBA1 gene is the greatest risk factor for developing Parkinson’s disease and dementia with Lewy bodies (DLB). However, it was unknown why some individuals who carry these variants develop PD while others do not.

The study discovered that loss-of-function variants in Commander complex genes contribute to an increase in Parkinson’s disease risk. By examining genomes from two independent cohorts, the scientists found that people with PD had more loss-of-function variants in Commander genes compared to those without the disease. This breakthrough opens the door to previously untapped drug targets for treating PD.

The study reveals that lysosomal dysfunction is a common feature of several neurodegenerative diseases, including Parkinson’s disease. The Commander complex plays an important role in maintaining lysosomal function, suggesting that drugs targeting this complex could improve the cell’s recycling system and potentially lead to new treatments for PD.

Future research will determine the extent to which the Commander complex contributes to other neurodegenerative disorders with lysosomal dysfunction. If Commander dysfunction is observed in these individuals, drugs targeting Commander could hold broader therapeutic potential for treating such disorders. In this context, Commander-targeting drugs could also complement other PD treatments, potentially leading to combinatorial therapies.

The study was published in the journal Science and was funded by a Research Program Award (R35). The findings of this research have significant implications for understanding Parkinson’s disease and developing new treatments for this complex disorder.

Continue Reading

Alzheimer's Research

Kilauea Volcano’s Ash Triggers Largest Open Ocean Phytoplankton Bloom

A new study by an international team of researchers revealed that a rare and large summertime phytoplankton bloom in the North Pacific Subtropical Gyre in the summer of 2018 was prompted by ash from Kilauea falling on the ocean surface approximately 1,200 miles west of the volcano.

Avatar photo

Published

on

When the Kīlauea Volcano erupted in May 2018, an enormous amount of ash was released into the atmosphere in a plume nearly five miles high. A new study by an international team of researchers revealed that a rare and large summertime phytoplankton bloom in the North Pacific Subtropical Gyre in the summer of 2018 was prompted by ash from Kīlauea falling on the ocean surface approximately 1,200 miles west of the volcano.

The research was published recently in JGR Oceans. “The scale and duration of this bloom were both massive, and probably the largest ever reported for the North Pacific,” said David Karl, study co-author, Victor and Peggy Brandstrom Pavel Professor, and director of the Center for Microbial Oceanography: Research and Education in the University of Hawai’i (UH) at Manoa School of Ocean and Earth Science and Technology.

Despite being one of the most active volcanoes in the world with multiple eruptions in the past 40 years, volcanic ash released from Kīlauea on Hawai’i Island had not previously been linked to open ocean phytoplankton blooms. The 2018 eruption of Kīlauea was one of the largest in more than 200 years, injecting millions of cubic feet of molten lava into the waters off the Big Island of Hawai’i and releasing an estimated 50 kilotons per day of sulfur dioxide and about 77 kilotons per day of carbon dioxide into the atmosphere.

Kīlauea’s impact near and far
Previous research led by UH Manoa oceanographers showed that as lava flowed into the ocean, it warmed nutrient-rich bottom waters, making them more buoyant. The nutrient-rich deep water rising to the sunlit surface stimulated phytoplankton growth, resulting in an extensive plume of microbes offshore of Hawai’i Island.

Volcanic ash can be transported much farther distances by winds, especially during explosive eruptions that inject materials high into the atmosphere. “After the 2018 eruption, the prevailing winds transported ash particles to the west,” said Wee Cheah, study corresponding-author and Senior Lecturer in the Institute of Ocean and Earth Sciences at Universiti Malaya.

The trajectories of the ash were recorded by Earth-orbiting satellites that detect changes in the optical clarity of the atmosphere, the so-called aerosol optical depth. Depending on the density, size, and shape of the particulate matter and local atmospheric conditions, especially rainfall, the ash eventually falls out of the atmosphere and into the surface ocean.

In addition to tracking atmospheric transport of ash across the Pacific Ocean, study lead author Chun Hoe Chow, Associate Professor in the Department of Marine Environmental Informatics at the National Taiwan Ocean University, and co-authors also used satellite data to detect ocean color, an indirect measure of the presence or absence of phytoplankton, which revealed a massive bloom near the dateline.

The team conducted a comprehensive analysis of the observations and investigated physical conditions to explain both the timing and the location of the surface bloom, a feature that is not typical in this region. “The waters in the open ocean of the Pacific are nutrient depleted and the addition of volcanic ash, especially iron in the ash, and to a lesser extent other trace elements and possibly phosphate, can stimulate the growth of marine phytoplankton,” said Karl.

Carbon out, carbon in
The growth of these specialized phytoplankton produced a lot of organic matter. When the organisms die and sink to the deep ocean, a large amount of organic carbon is exported from the surface, essentially removing carbon from the upper ocean and atmosphere.

“Our estimates are that export of organic carbon may be equivalent to about half of the carbon dioxide initially released from the eruption,” said Karl. “This marine carbon dioxide sequestration is a natural process that probably occurs whenever volcanic eruptions inject ash into the atmosphere and carry that particulate matter out to sea.”

The research team is prepared to track future volcanic eruptions and their effects on phytoplankton blooms. If another major eruption occurs, they plan to deploy a research vessel to study the bloom’s development and response in real-time.

Continue Reading

Trending